Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sihuan Pharma to Distribute Vascular Drug for Benxi Leilong

publication date: Nov 17, 2010
Sihuan Pharma has struck a deal to distribute alprostadil injection, a vasodilator, for Benxi Leilong Pharmaceutical Co. Sihuan will have exclusive rights for 30 years to distribute the drug to its network of almost 10,000 hospitals in China. According to Sihuan, alprostadil injection is one of the best-selling cardio-cerebral vascular drugs in China. The drug is a natural fit for Sihuan, which already makes and distributes a portfolio of 14 cardio-cerebral vascular drugs. More details....

Stock Symbol: (HKEX: 0460)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital